# Cadre Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2025

- Company: [Cadre Holdings, Inc.](/companies/cdre.md) (CIK 1860543)
- Form: 10-Q
- Filed: 2025-05-06
- Accepted by EDGAR: May 6, 2025, 16:17 ET
- Period: 2025-03-31
- Accession: 0001558370-25-006502
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860543/000155837025006502/cdre-20250331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860543/000155837025006502/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-01-01 to 2025-03-31 | $130.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-01-01 to 2025-03-31 | $74.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2025-01-01 to 2025-03-31 | $56.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2025-01-01 to 2025-03-31 | $41.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-01-01 to 2025-03-31 | $13.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-01-01 to 2025-03-31 | $2.2m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-01-01 to 2025-03-31 | $3.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-01-01 to 2025-03-31 | $9.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-01-01 to 2025-03-31 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-01-01 to 2025-03-31 | $0.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-01-01 to 2025-03-31 | 40,980,861 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-01-01 to 2025-03-31 | $17.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2025-01-01 to 2025-03-31 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2025-01-01 to 2025-03-31 | $3.9m | us-gaap:PaymentsOfDividends |
| Current assets | at 2025-03-31 | $332.5m | us-gaap:AssetsCurrent |
| Total assets | at 2025-03-31 | $656.3m | us-gaap:Assets |
| Current liabilities | at 2025-03-31 | $93.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-03-31 | $338.7m | us-gaap:Liabilities |
| Long-term debt | at 2025-03-31 | $209.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-03-31 | $11.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2025-03-31 | $317.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 36,251 characters.

*The following discussion and analysis of the financial condition and results of operations of Cadre Holdings, Inc. (D/B/A The Safariland Group) (“Cadre,” “the Company” “we,” “us” and “our”) should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of Cadre’s control. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ materially from those projected in the forward- looking statements include, but are not limited to, those discussed in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2024 and the section entitled “Cautionary Statement Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q.*

### Our Business

Cadre is a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment and duty gear through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products including uniforms, optics, boots, firearms and ammunition. The majority of our diversified product offering is governed by rigorous safety standards and regulations. Demand for our products is driven by technological advancement as well as recurring modernization and replacement cycles for the equipment to maintain its efficiency, effective performance and regulatory compliance.

We service the ever-changing needs of our end users by investing in research and development for new product innovation and technical advancements that continually raise the standards for safety equipment. Our target end user base includes domestic and international first responders such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections and numerous foreign government agencies in over 100 countries.

The following table sets forth a summary of our financial highlights for the periods indicated:

*(in thousands)*

| ​ ​ | ​ ​ ​ | ​ ​ Three Months Ended March 31, 2025 | ​ ​ | ​ ​ 2024 |
| --- | --- | ---: | --- | ---: |
| Net sales |  | $130,106 |  | $137,860 |
| Net income | ​ | $9,248 | ​ | $6,928 |
| Adjusted EBITDA(1) | ​ | $20,497 | ​ | $24,488 |

(1) Adjusted EBITDA is a non-GAAP financial measure. See “*Non-GAAP Measures”* below for our definition of, and additional information about, Adjusted EBITDA, and for a reconciliation to net income, the most directly comparable U.S. GAAP financial measure.

Net sales decreased by $7.8 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily as a result of a decrease in explosive ordnance disposal (“EOD”) and armor products, partially offset by increases from recent acquisitions and international crowd control products.

### (in thousands, except share and per share amounts)

Net income increased by $2.3 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily as a result of the non-recurrence of acquisition related costs incurred in 2024.

### KEY PERFORMANCE METRICS

### Orders backlog

We monitor our orders backlog, which we believe is a forward-looking indicator of potential sales. Our orders backlog for products includes all orders that have been received and are believed to be firm. Due to municipal government procurement rules, in certain cases orders included in backlog are subject to budget appropriation or other contract cancellation clauses. Consequently, our orders backlog may differ from actual future sales. Orders backlog can be helpful to investors in evaluating the performance of our business and identifying trends over time.

The following table presents our orders backlog as of the periods indicated:

| ​ ​ | ​ ​ | ​ ​ March 31, 2025 | ​ ​ | ​ ​ December 31, 2024 |
| --- | --- | ---: | --- | ---: |
| Orders backlog | ​ | $151,185 | ​ | $128,814 |

Orders comprising backlog as of a given balance sheet date are typically invoiced in subsequent periods. The majority of our products are generally processed and shipped within one to three weeks of an order being placed, though the fulfillment time for certain products, for example, explosive ordnance disposal equipment, may take three months or longer. Our orders backlog could experience volatility between periods, including as a result of customer order volumes and the speed of our order fulfilment, which in turn may be impacted by the nature of products ordered, the amount of inventory on hand and the necessary manufacturing lead time.

Orders backlog increased by $22.4 million as of March 31, 2025 compared to December 31, 2024, primarily due to increases of $10.6 million from EOD products, $6.6 million from chemiluminescent products, $2.8 million from duty gear products, and $2.2 million from structural armor products, partially offset by a reduction of $1.4 million from delivery of large international crowd control orders.

### (in thousands, except share and per share amounts)

### RESULTS OF OPERATIONS

In order to reflect the way our chief operating decision maker reviews and assesses the performance of the business, Cadre has determined that it has two reportable segments — the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of our business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products. Segment information is consistent with how the chief operating decision maker, our chief executive officer, reviews the business, makes investing and resource allocation decisions and assesses operating performance.

The following table presents data from our results of operations for the three months ended March 31, 2025 and 2024 (in thousands unless otherwise noted):

| ​ ​ ​ | ​ ​ ​ | ​ ​ Three Months Ended March 31, 2025 | ​ ​ | ​ ​ 2024 | ​ ​ ​ | ​ ​ ​ ​ % Chg ​ |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Net sales | ​ | $130,106 | ​ | $137,860 | ​ | (5.6)% |
| Cost of goods sold | ​ | 73,975 | ​ | 80,232 | ​ | (7.8)% |
| **Gross profit** | ​ | 56,131 | ​ | 57,628 | ​ | (2.6)% |
| ​ | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| Operating expenses | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| Selling, general and administrative | ​ | 41,753 | ​ | 40,719 | ​ | 2.5% |
| Restructuring and transaction costs | ​ | 698 | ​ | 3,087 | ​ | (77.4)% |
| Related party expense | ​ | 128 | ​ | 1,843 | ​ | (93.1)% |
| **Total operating expenses** | ​ | 42,579 | ​ | 45,649 | ​ | (6.7)% |
| **Operating income** | ​ | 13,552 | ​ | 11,979 | ​ | 13.1% |
| ​ | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| Other expense | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| Interest expense | ​ | (2,231) | ​ | (1,637) | ​ | 36.3% |
| Other income (expense), net | ​ | 1,287 | ​ | (1,444) | ​ | (189.1)% |
| **Total other expense, net** | ​ | (944) | ​ | (3,081) | ​ | (69.4)% |
| ​ | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| Income before provision for income taxes | ​ | 12,608 | ​ | 8,898 | ​ | 41.7% |
| Provision for income taxes | ​ | (3,360) | ​ | (1,970) | ​ | 70.6% |
| ​ | ​ | ​ ​ | ​ | ​ ​ | ​ | ​ ​ |
| **Net income** | ​ | $9,248 | ​ | $6,928 | ​ | 33.5% |

The following tables present segment data for the three months ended March 31, 2025 and 2024 (in thousands):

| ​ ​ ​ ​ | ​ ​ | ​ ​ Three Months Ended March 31, 2025 ​ ​ Product | ​ ​ | ​ ​ ​ ​ Distribution | ​ ​ | ​ ​ Reconciling Items(1) | ​ ​ | ​ ​ ​ ​ Total |
| --- | --- | ---: | --- | ---: | --- | ---: | --- | ---: |
| Net sales |  | $112,735 | ​ | $27,862 | ​ | $(10,491) |  | $130,106 |
| Cost of goods sold | ​ | ​ 62,625 | ​ | ​ 21,841 | ​ | ​ (10,491) | ​ | ​ 73,975 |
| Gross profit | ​ | $50,110 | ​ | $6,021 | ​ | $— | ​ | $56,131 |

| ​ ​ ​ ​ | ​ ​ | ​ ​ Three Months Ended March 31, 2024 ​ ​ Product | ​ ​ | ​ ​ ​ ​ Distribution | ​ ​ | ​ ​ Reconciling Items(1) | ​ ​ | ​ ​ ​ ​ Total |
| --- | --- | ---: | --- | ---: | --- | ---: | --- | ---: |
| Net sales |  | $118,785 | ​ | $28,191 | ​ | $(9,116) |  | $137,860 |
| Cost of goods sold | ​ | ​ 67,764 | ​ | ​ 21,557 | ​ | ​ (9,089) | ​ | ​ 80,232 |
| Gross profit | ​ | $51,021 | ​ | $6,634 | ​ | $(27) | ​ | $57,628 |

(1) Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

### (in thousands, except share and per share amounts)

### Comparison of Three months Ended March 31, 2025 to Three months Ended March 31, 2024

*Net sales.* Product segment net sales decreased by $6.1 million, or 5.1%, from $118.8 million to $112.7 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreases of $8.7 million from EOD products and $7.2 million from armor products, both from large orders delivered in 2024, partially offset by increases of $9.1 million from recent acquisitions and $1.4 million from international crowd control products. Distribution segment net sales decreased by $0.3 million, or 1.2%, from $28.2 million to $27.9 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreased demand for hard goods. Reconciling items consisting primarily of intercompany eliminations were $10.5 million and $9.1 million for the three months ended March 31, 2025 and 2024, respectively.

*Cost of goods sold and gross profit.* Product segment cost of goods sold decreased by $5.2 million, or 7.6%, from $67.8 million to $62.6 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreased volumes and the absence of inventory step-up amortization, partially offset by increased costs to manufacture product. Product segment gross profit as a percentage of net sales increased by 150 basis points to 44.4% for the three months ended March 31, 2025 from 43.0% for the three months ended March 31, 2024, mainly driven by favorable mix, favorable pricing net of material inflation and the absence of inventory step-up amortization, partially offset by lower volumes. Distribution segment cost of goods sold increased by $0.2 million, or 1.3%, from $21.6 million to $21.8 million for the three months ended March 31, 2025 as compared to the same period in 2024, primarily due to unfavorable mix. Distribution segment gross profit as a percentage of net sales decreased by 192 basis points to 21.6% for the three months ended March 31, 2025 from 23.5% for the three months ended March 31, 2024, mainly driven by unfavorable mix. Reconciling items consisting primarily of intercompany eliminations were $10.5 million and $9.1 million for the three months ended March 31, 2025 and 2024, respectively.

*Selling, general and administrative.* Selling, general and administrative increased by $1.0 million, or 2.5%, for the three months ended March 31, 2025 as compared to the same period in 2024, primarily due to recent acquisitions.

*Restructuring and transaction costs.* Restructuring and transaction costs decreased by $2.4 million for the three months ended March 31, 2025 primarily due to costs incurred in 2024 associated with the ICOR and Alpha Safety acquisitions.

*Related party expense.* Related party expense, which ordinarily consists of rent expense related to distribution warehouses and retail stores that we lease from related parties, decreased by $1.7 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024 primarily due to a $1.8 million transaction fee paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, in connection with the acquisition of Alpha Safety.

*Interest expense.* Interest expense increased by $0.6 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to the debt refinancing that occurred in the fourth quarter of 2024.

*Other income (expense), net.* Other income, net was $1.3 million for the three months ended March 31, 2025 as compared to Other expense, net of $1.4 million for the three months ended March 31, 2024, primarily due to changes in foreign currency exchange rates.

*Provision for income taxes.* Provision for income taxes was $3.4 million for the three months ended March 31, 2025 compared to $2.0 million for the three months ended March 31, 2024. The effective tax rate was 26.6% for the three months ended March 31, 2025 and was higher than the statutory rate primarily due to state taxes and non-deductible executive compensation. The effective tax rate was 22.1% for the three months ended March 31, 2024 and was lower than the statutory rate primarily due to the vesting of stock compensation, partially offset by non-deductible executive compensation.

### NON-GAAP MEASURES

This Quarterly Report on Form 10-Q includes EBITDA and Adjusted EBITDA, which are non-GAAP financial measures that we use to supplement our results presented in accordance with U.S. GAAP. EBITDA is defined as net income before depreciation and amortization expense, interest expense and provision for income tax. Adjusted EBITDA represents EBITDA that excludes

### (in thousands, except share and per share amounts)

restructuring and transaction costs, other (income) expense, net, stock-based compensation expense, stock-based compensation payroll tax expense, long-term incentive plan (“LTIP”) bonus, amortization of inventory step-up and contingent consideration expense as these items do not represent our core operating performance.

EBITDA and Adjusted EBITDA are performance measures that we believe are useful to investors and analysts because they illustrate the underlying financial and business trends relating to our core, recurring results of operations and enhance comparability between periods. Adjusted EBITDA is considered by our board of directors and management as an important factor in determining performance-based compensation.

EBITDA and Adjusted EBITDA are not recognized measures under U.S. GAAP and are not intended to be a substitute for any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly-titled measures of performance of other companies. Investors should exercise caution in comparing our non-GAAP measures to any similarly titled measures used by other companies. These non-GAAP financial measures exclude certain items required by U.S. GAAP and should not be considered as alternatives to information reported in accordance with U.S. GAAP.

The table below presents our EBITDA and Adjusted EBITDA reconciled to the most comparable GAAP financial measures for the periods indicated:

*(in thousands)*

| ​ ​ | ​ | ​ ​ Three Months Ended March 31, 2025 | ​ | ​ ​ 2024 |
| --- | --- | ---: | --- | ---: |
| Net income | ​ | $9,248 | ​ | $6,928 |
| Add back: | ​ |  |  |  |
| Depreciation and amortization | ​ | 3,856 |  | 3,942 |
| Interest expense | ​ | 2,231 |  | 1,637 |
| Provision for income taxes | ​ | 3,360 |  | 1,970 |
| **EBITDA** | ​ | $18,695 |  | $14,477 |
| Add back: | ​ |  |  |  |
| Restructuring and transaction costs(1) | ​ | 698 |  | 4,837 |
| Other (income) expense, net(2) | ​ | (1,287) |  | 1,444 |
| Stock-based compensation expense(3) | ​ | ​ 1,968 | ​ | ​ 2,067 |
| Stock-based compensation payroll tax expense(4) | ​ | ​ 92 | ​ | ​ 393 |
| LTIP bonus(5) | ​ | — |  | 50 |
| Amortization of inventory step-up(6) | ​ | ​ — | ​ | ​ 769 |
| Contingent consideration expense(7) | ​ | ​ 331 | ​ | ​ 451 |
| **Adjusted EBITDA** | ​ | $20,497 |  | $24,488 |

(1) Reflects the “Restructuring and transaction costs” line item on our condensed consolidated statements of operations and comprehensive income, which primarily includes transaction costs composed of legal and consulting fees, and $1.8 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Alpha Safety, which is included in related party expense in the Company’s condensed consolidated statements of operations and comprehensive income for the three months ended March 31, 2024.

(2) Reflects the “Other income (expense), net” line item on our condensed consolidated statement of operations and comprehensive income, and primarily includes gains and losses due to fluctuations in foreign currency exchange rates.

(3) Reflects compensation expense related to equity classified stock-based compensation plans.

(4) Reflects payroll taxes associated with vested stock-based compensation awards.

(5) Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

### (in thousands, except share and per share amounts)

(6) Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

(7) Reflects contingent consideration expense related to the acquisition of ICOR.

Adjusted EBITDA decreased by $4.0 million for the three months ended March 31, 2025 as compared to 2024, primarily due to lower sales volume partially offset by favorable pricing net of material inflation, favorable mix, and the absence of inventory step-up amortization.

### LIQUIDITY AND CAPITAL RESOURCES

Liquidity refers to our ability to generate sufficient cash flows to meet the cash requirements of our business operations, including working capital needs, capital expenditures, debt service, acquisitions and other commitments. Our principal sources of liquidity have been cash provided by operating activities, cash on hand and amounts available under our revolving loans.

For the three months ended March 31, 2025, net cash provided by operating activities totaled $17.4 million and as of March 31, 2025, cash and cash equivalents totaled $133.4 million. We believe that our cash flows from operations and cash on hand, and available borrowing capacity under our existing credit facilities (as described below) will be adequate to meet our liquidity requirements for at least the 12 months following the date of this Quarterly Report on Form 10-Q. Our future capital requirements will depend on several factors, including future acquisitions and investments in our manufacturing facilities and equipment. We could be required, or could elect, to seek additional funding through public or private equity or debt financings; however, additional funds may not be available on terms acceptable to us, if at all.

### Debt

As of March 31, 2025 and December 31, 2024, we had $220.5 million and $223.2 million in outstanding debt, net of debt discounts and debt issuance costs, respectively, primarily related to the term loan facilities.

#### 2024 Credit Agreement

On December 20, 2024 (the “2024 Credit Agreement Closing Date”), the Company refinanced its existing credit facilities and entered into an Amended and Restated Credit Agreement (the “2024 Credit Agreement”), whereby Safariland, LLC, as borrower (the “2024 Borrower”), the Company, and certain domestic subsidiaries of the 2024 Borrower, as guarantors (the “2024 Guarantors”), closed on and received funding under the 2024 Credit Agreement with PNC, as administrative agent, swingline lender, and issuing lender, along with several other lenders (collectively, the “2024 Lenders”). The 2024 Credit Agreement amends and restates the 2021 Credit Agreement in its entirety.

Pursuant to the 2024 Credit Agreement, the 2024 Borrower (i) borrowed $225.0 million under a term loan facility (the “2024 Term Loans”), (ii) may borrow up to $175.0 million under a revolving credit facility (the “2024 Revolving Loan”), including up to $30.0 million for letters of credit and up to $10.0 million for swingline loans, (iii) may borrow up to $115.0 million under a delayed draw term loan A-1 facility (the “DDTL A-1 Facility”) available through June 20, 2025, and (iv) may borrow up to $75.0 million under a delayed draw term loan A-2 facility (the “DDTL A-2 Facility”) available through June 20, 2026. Each of these facilities matures on December 20, 2029. The proceeds of the 2024 Term Loans were used to refinance the outstanding term loans under the 2021 Credit Agreement and to pay fees and expenses incurred in connection with entering into the 2024 Credit Agreement. The 2024 Credit Agreement also permits the 2024 Borrower, subject to certain requirements, to arrange with lenders for an aggregate of $100.0 million (or more if certain leverage ratios are met) of additional revolving and/or term loan commitments (both of which are currently uncommitted).

The 2024 Borrower may elect to have borrowings under the 2024 Credit Agreement bear interest at either (i) a base rate plus an applicable margin ranging from 0.50% to 1.50% per annum or (ii) a term SOFR rate plus an applicable margin ranging from 1.50% to 2.50% per annum, in each case based on the Company’s consolidated total net leverage ratio. The 2024 Borrower is also required to

### (in thousands, except share and per share amounts)

pay a commitment fee on the unused portion of the 2024 Revolving Loan, the DDTL A-1 Facility, and the DDTL A-2 Facility, ranging from 0.175% to 0.25% per annum, based on the Company’s consolidated total net leverage ratio.

The 2024 Term Loans require scheduled quarterly principal payments of 1.25% of the original aggregate principal amount, beginning March 31, 2025, with the balance due at maturity.

The 2024 Credit Agreement is guaranteed, jointly and severally, by the 2024 Guarantors and, subject to certain exceptions, secured by a first-priority security interest in substantially all of the assets of the 2024 Borrower and the 2024 Guarantors pursuant to an Amended and Restated Security and Pledge Agreement and an Amended and Restated Guaranty and Suretyship Agreement, each dated as of the 2024 Credit Agreement Closing Date.

The 2024 Credit Agreement contains customary representations and warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the 2024 Borrower or any 2024 Guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, dispositions, and mandatory prepayments in connection with certain liquidity events. Additionally, the 2024 Credit Agreement contains certain restrictive debt covenants, which require us to: (i) maintain a minimum fixed charge coverage ratio of 1.25 to 1.00, starting with the quarter ended December 31, 2024, which is to be determined for each quarter end on a trailing four quarter basis and (ii) maintain a quarterly maximum consolidated total net leverage ratio of 4.00 to 1.00 from the quarter ended December 31, 2024 until the quarter ended March 31, 2026, and thereafter 3.50 to 1.00, which is in each case to be determined on a trailing four quarter basis; provided that under certain circumstances and subject to certain limitations, in the event of a material acquisition, we may temporarily increase the consolidated total net leverage ratio by up to 0.50 to 1.00 for four fiscal quarters following such acquisition, subject to a maximum consolidated total net leverage ratio of 4.00 to 1.00. Furthermore, the 2024 Credit Agreement also includes customary events of default, including non-payment of principal, interest, or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payments on other material indebtedness, bankruptcy and insolvency events, material judgments, and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the 2024 Credit Agreement may be accelerated, and the Lenders could foreclose on their security interests in the assets of the Borrower and the Guarantors. As of May 2, 2025, there were no amounts outstanding under the Revolving Loan.

The foregoing description of the 2024 Credit Agreement does not purport to be complete and is qualified in its entirety by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on December 23, 2024, and is incorporated herein by reference as though fully set forth herein.

There were no amounts outstanding under the 2024 Revolving Loan as of March 31, 2025 and December 31, 2024. As of March 31, 2025, there were $2.2 million in outstanding letters of credit and $172.8 million of availability.

#### Canadian Credit Facility

On October 14, 2021, Med-Eng Holdings ULC and Pacific Safety Products Inc., the Company’s Canadian subsidiaries, as borrowers (the “Canadian Borrowers”), and Safariland, LLC, as guarantor (the “Canadian Guarantor”), closed on a line of credit pursuant to a Loan Agreement (the “Canadian Loan Agreement”) and a Revolving Line of Credit Note (the “Note”) with PNC Bank Canada Branch (“PNC Canada”), as lender pursuant to which the Canadian Borrowers may borrow up to CDN$10.0 million under a revolving line of credit (including up to $3.0 million for letters of credit) (the “Revolving Canadian Loan”). The Revolving Canadian Loan matures on July 23, 2026. The Canadian Loan Agreement is guaranteed by the Canadian Guarantor pursuant to a Guaranty and Suretyship Agreement.

The Canadian Borrowers may elect to have borrowings either in United States dollars or Canadian dollars under the Canadian Loan Agreement, which will bear interest at a base rate or SOFR, in each case, plus an applicable margin, in the case of borrowings in United States dollars, or at a Canadian Prime Rate (as announced from time to time by PNC Canada) or a Canadian deposit offered rate (“CDOR”) as determined from time to time by PNC Canada in accordance with the Canadian Loan Agreement. The applicable

### (in thousands, except share and per share amounts)

margin for these borrowings will range from 0.50% to 1.50% per annum, in the case of base rate borrowings and Canadian Prime Rate borrowings, and 1.50% to 2.50% per annum, in the case of SOFR borrowings and CDOR borrowings. The Canadian Loan Agreement also requires the Canadian Borrowers to pay (i) an unused line fee on the unused portion of the loan commitments in an amount ranging between 0.175% and 0.25% per annum, based upon the level of the Company’s consolidated total net leverage ratio, and (ii) an upfront fee equal to 0.25% of the principal amount of the Note.

There were no amounts outstanding under the Revolving Canadian Loan as of March 31, 2025 and December 31, 2024.

The Canadian Loan Agreement also contains customary representations and warranties, and affirmative and negative covenants, including, among others, limitations on additional indebtedness, entry into new lines of business, entry into guarantee agreements, making of any loans or advances to, or investments in, any other person, restrictions on liens on the assets of the Canadian Borrowers and mergers, transfers of assets and acquisitions. The Canadian Loan Agreement and Note also contain customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the Canadian Loan Agreement may be accelerated. As of May 2, 2025, there were no amounts outstanding under the Revolving Canadian Loan.

The foregoing description of the Canadian Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the Canadian Loan Agreement, which is exhibit 10.18 to our Annual Report on Form 10-K for the year ended December 31, 2022, and is incorporated herein by reference as though fully set forth herein.

### Cash Flows

The following table presents a summary of our cash flows for the periods indicated:

*(in thousands)*

| ​ ​ | ​ | ​ ​ Three Months Ended March 31, 2025 | ​ ​ ​ 2024 |
| --- | --- | ---: | ---: |
| Net cash provided by operating activities | ​ | $17,391 | $2,137 |
| Net cash used in investing activities | ​ | (1,309) | (142,636) |
| Net cash (used in) provided by financing activities | ​ | (7,812) | 139,786 |
| Effects of foreign exchange rates on cash and cash equivalents | ​ | 228 | 74 |
| Change in cash and cash equivalents | ​ | 8,498 | (639) |
| Cash and cash equivalents, beginning of period | ​ | 124,933 | 87,691 |
| Cash and cash equivalents, end of period | ​ | $133,431 | $87,052 |

#### Net cash provided by operating activities

During the three months ended March 31, 2025, net cash provided by operating activities of $17.4 million resulted primarily from net income of $9.2 million, a $3.9 million add-back to net income for depreciation and amortization, a $2.0 million add-back to net income for stock-based compensation, and a net add-back to net income of $1.6 million for changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily driven by a decrease in accounts receivable of $10.6 million and an increase in inventories of $9.1 million.

During the three months ended March 31, 2024, net cash provided by operating activities of $2.1 million resulted primarily from net income of $6.9 million, a $3.9 million add back to net income for depreciation and amortization, a $2.1 million add-back to net income for stock-based compensation and a net deduction to net income of $15.2 million for changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily driven by a decrease in accounts payable and other liabilities of $21.7 million, a decrease in accounts receivable of $2.7 million and a decrease in prepaid expenses and other assets of $2.0 million.

### (in thousands, except share and per share amounts)

#### Net cash used in investing activities

During the three months ended March 31, 2025, we used $1.3 million of cash in investing activities for the purchase of property and equipment.

During the three months ended March 31, 2024, we used $142.6 million of cash in investing activities, primarily consisting of $141.3 million for the acquisition of ICOR and Alpha Safety.

#### Net cash (used in) provided by financing activities

During the three months ended March 31, 2025, we used $7.8 million of cash in financing activities, consisting of principal payments on term loans of $2.8 million, taxes paid in connection with employee stock transactions of $1.1 million and dividends distributed of $3.9 million.

During the three months ended March 31, 2024, net cash provided by financing activities of $139.8 million resulted primarily from proceeds from term loans of $80.0 million and proceeds from the secondary offering of $73.5 million, partially offset by taxes paid in connection with employee stock transactions of $5.3 million and dividends distributed of $3.3 million.

### Contractual Obligations

Our long-term contractual obligations generally include our debt and related interest payments and operating and finance lease payments for our property and equipment, and are expected to be funded from cash-on-hand, cash from operations and availability under our existing credit facilities. There were no significant changes to our contractual obligations from those disclosed in the Quarterly Report on Form 10-Q for the three months ended March 31, 2024.

### Off-Balance Sheet Arrangements

We do not engage in off-balance sheet financing arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

### CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES

Our condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. Preparation of the financial statements requires us to make judgments, estimates and assumptions that impact the reported amount of net sales and expenses, assets and liabilities and the disclosure of contingent assets and liabilities. We consider an accounting judgment, estimate or assumption to be critical when the estimate or assumption is complex in nature or requires a high degree of judgment and when the use of different judgments, estimates and assumptions could have a material impact on our condensed consolidated financial statements. While our significant accounting policies are described in more detail in notes in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the year ended December 31, 2024.

### Recently Adopted and Issued Accounting Pronouncements

Recently issued and adopted accounting pronouncements are described in notes to our audited consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

### (in thousands, except share and per share amounts)

### Emerging Growth Company

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation or golden parachute arrangements.

In addition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our condensed consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates.

## Market risk

As filed, 4,502 characters.

We have in the past and may in the future be exposed to certain market risks, including interest rate, foreign currency exchange in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial condition or results of operations due to adverse changes in financial market prices and rates. These risks are not significant to our results of operations, but they may be in the future. We do not hold or issue financial instruments for speculative or trading purposes. There have not been material changes in market risk exposures as of March 31, 2025.

### Interest rate risk

Changes in interest rates affect the amount of interest expense we are required to pay on our floating rate debt. As of March 31, 2025, we had $222.2 million in outstanding floating rate debt, which bears interest at one-month SOFR (4.32% as of March 31, 2025) plus applicable margin.

We entered into the Swap Agreements to convert a portion of the interest rate exposure on our floating rate debt from variable to fixed and designated them as cash flow hedges. Under the terms of the Swap Agreements, we receive payments based on the 1-month SOFR. A portion of the amount included in accumulated other comprehensive loss is reclassified into interest expense, net as a yield adjustment as interest is either paid or received on the hedged debt. The fair value of our Swap Agreements is based upon Level 2 inputs. We have considered our own credit risk and the credit risk of the counterparties when determining the fair value of our Swap Agreements.

We performed a sensitivity analysis on the principal amount of debt as of March 31, 2025, as well as the effect of our Swap Agreements. Further, in this sensitivity analysis, the change in interest rates is assumed to be applicable for an entire year. On an annual basis, a change of 100 basis points in the applicable interest rate would cause a change in interest expense of $2.2 million on the principal amount of debt and a $0.6 million change in interest expense when including the effect of our Swap Agreements.

As of March 31, 2025, we had the following Swap Agreements (in thousands):

| ​ Effective Date | ​ | ​ ​ Notional Amount | ​ | ​ ​ Fixed Rate |
| --- | --- | ---: | --- | ---: |
| September 30, 2021 through July 23, 2026 | ​ | $82,500 | ​ | 0.812% |
| May 31, 2023 through July 23, 2026 | ​ | $45,000 |  | 3.905% |
| February 14, 2025 through December 20, 2029 |  | $38,883 |  | 4.080% |

During the three months ended March 31, 2025, there were no interest rate swap agreements that expired.

### (in thousands, except share and per share amounts)

### Foreign currency exchange rate risk

Our operations are geographically diverse and we are exposed to foreign currency exchange risk, primarily the Canadian dollar and Mexican peso, related to our transactions and our subsidiaries’ balances that are denominated in currencies other than the U.S. dollar, our functional currency.

The Company has entered into forward contracts to hedge forecasted Mexican peso denominated costs associated with our Mexican subsidiary. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are recorded in other comprehensive (loss) income and are reclassified from accumulated other comprehensive loss into earnings in the period the hedged item impacts earnings.

Significant currency fluctuations could impact the comparability of our results of operations between periods. A 10% increase or decrease in the value of the Canadian dollar to the U.S. dollar would have caused our reported net sales to increase or decrease by approximately $0.9 million for the three months ended March 31, 2025. A 10% increase or decrease in the value of the Canadian dollar to the U.S. dollar would have caused our reported net income to increase or decrease by approximately $0.1 million for the three months ended March 31, 2025, excluding unrealized gains or losses from remeasurement. A 10% increase or decrease in the value of the Mexican peso to the U.S. dollar would have caused our reported net income to increase or decrease by approximately $0.5 million for the three months ended March 31, 2025, respectively, excluding unrealized gains or losses from remeasurement and the impact of cash flow hedges.

## Controls and procedures

As filed, 2,598 characters.

### Evaluation of Disclosure Controls and Procedures

The Company’s management carried out an evaluation, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, its principal executive officer and principal financial officer, respectively, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(c) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of March 31, 2025, pursuant to Exchange Act Rule 13a-15. Such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports we file or submit under the Exchange Act is (i) recorded, processed, summarized, evaluated and reported, as applicable, within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to the appropriate management on a basis that permits timely decisions regarding disclosure. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of March 31, 2025 were effective.

### Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the three months ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

### Limitations on Effectiveness of Controls and Procedures

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls can prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. There are inherent limitations in all control systems, including the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of one or more persons. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential conditions. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.

## Risk factors

As filed, 178 characters.

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Filed May 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-006502. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.